DR. JEFFREY DAVID CHULAY, MD
Osteopathic Medicine at 97 Ter, Gainesville, FL
License number
Florida 58502
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
4525 SW 97Th Ter, Gainesville, FL 32608
Phone
(352) 372-3212
Personal information
See more information about JEFFREY DAVID CHULAY at radaris.comName
Address
Phone
4525 97Th St, Gainesville, FL 32608
4525 SW 97Th Ter, Gainesville, FL 32608
Professional information
See more information about JEFFREY DAVID CHULAY at trustoria.com
Vice President And Cmo At Agtc
Vice President And Cmo At Agtc
Position:
Vice President and CMO at AGTC
Location:
Gainesville, Florida Area
Industry:
Biotechnology
Work:
AGTC
-
Vice President and CMO
AlphaVax
2001 - 2007
-
Chief Medical Officer
Dr. Jeffrey D Chulay, Gainesville FL - MD (Doctor of Medicine)
Dr. Jeffrey D Chulay, Gainesville FL - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
4525 SW 97Th Ter, Gainesville 32608
(352) 372-3212 (Phone)
(352) 372-3212 (Phone)
Certifications:
Infectious Disease, 1978, Internal Medicine, 1973
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1970
Cleveland Metropolitan General Hospital
Walter Reed Army Medical Center
Northwestern Center Feinberg School of Medicine
Graduated: 1970
Cleveland Metropolitan General Hospital
Walter Reed Army Medical Center
Promoters, Expression Cassettes, Vectors, Kits, And Methods For The Treatment Of Achromatopsia And Other Diseases
Promoters, Expression Cassettes, Vectors, Kits, And Methods For The Treatment Of Achromatopsia And Other Diseases
US Patent:
2013031, Nov 28, 2013
Filed:
Jul 8, 2013
Appl. No.:
13/936728
Inventors:
Guo-Jie Ye - Gainesville FL, US
Jeffrey D. Chulay - Gainesville FL, US
Jeffrey D. Chulay - Gainesville FL, US
International Classification:
C12N 15/85
US Classification:
514 44 R, 536 241, 4353201
Abstract:
The present invention provides isolated promoters, transgene expression cassettes, vectors, kits, and methods for treatment of genetic diseases that affect the cone cells of the retina.